March 21, 2019March 21, 2019
Resverlogix Obtains Funding for Phase 2 Trial Testing Apabetalone in PAH
News, PAH News
Resverlogix announced that it has received funding from the Canadian Institutes for Health Research for a Phase 2 clinical ... Read more
March 20, 2019March 20, 2019
Opsumit Has Potential to Improve Right Ventricle Function in PAH Patients, Phase 4 Data Show
News, PAH News
Treatment with Opsumit (macitentan) can significantly improve the heart’s right ventricular function, reverse cardiac tissue remodeling, and reduce ... Read more
March 18, 2019March 18, 2019
Cell Therapies Show Potential as Treatment for PAH, Review Finds
News, PAH News
Regenerative cell therapy can induce significant improvements in key clinical features of pulmonary arterial hypertension (PAH) in animal models, ... Read more
March 15, 2019March 15, 2019
Defining Five Main Categories of Pulmonary Wellness: A Rehab Specialist’s Advice
News
“The whole is greater than the sum of its parts.” — Aristotle In today’s healthcare environment, an overwhelming percentage of ... Read more
March 15, 2019March 15, 2019
Estrogen May Help Protect Against Heart Changes in PAH, Animal Study Suggests
News, PAH News
Estrogen, one of the major female sex hormones, has a protective effect in pulmonary arterial hypertension (PAH) by halting ... Read more
March 15, 2019March 19, 2019
PH Life Feels Like Residing in a Waiting Room
Columns, Recharged and Rewired - a Column by Brittany Foster
I get anxious just thinking about what it’s like sitting in a waiting room at a doctor’s office. In ... Read more
March 14, 2019March 19, 2019
Liquidia’s LIQ861 Safe and Effective in PAH Patients, Phase 3 Trial Suggests
News, PAH News
A Phase 3 clinical trial testing LIQ861 met its primary objective, showing that the investigational inhaled dry powder treprostinil formulation ... Read more
March 14, 2019March 20, 2019
Brexit Could Have Real Effects for UK Rare Disease Patients, Experts Warn
News
Madeline Collin, a 24-year-old activist with Gaucher disease, worries that patients like her will suffer deeply if Britain leaves ... Read more
March 13, 2019March 13, 2019
1st Participant Enrolled in Phase 2 Trial of Levosimendan for PH Patients with Heart Failure
News, PH News
The first participant has been enrolled in a Phase 2 trial testing the investigational therapy levosimendan in pulmonary hypertension (PH) ... Read more
March 12, 2019March 12, 2019
Moral Dilemmas Complicate Treatment of Rare Diseases, Says Israeli Bioethicist
News
With each new advance in medicine comes ethical dilemmas, from fertility treatments and newborn screening, to vaccinations, gene therapies ... Read more
March 11, 2019March 11, 2019
Study Reveals Possible Reason for Women’s Higher Risk of PAH
News, PAH News
Women’s pulmonary artery muscle cells produce more of a signal molecule called hypoxia-inducible factor 1-alpha (HIF1α), which may ... Read more
March 8, 2019March 15, 2019
With PH, I Choose to Be Cautiously Optimistic
Columns, Recharged and Rewired - a Column by Brittany Foster
Black-and-white thinking is something that I have mastered for the majority of my life. In the psychology world, the ... Read more

March 21, 2019March 21, 2019

Resverlogix Obtains Funding for Phase 2 Trial Testing Apabetalone in PAH

News, PAH News

Resverlogix announced that it has received funding from the Canadian Institutes for Health Research for a Phase 2 clinical study investigating the safety and efficacy of its proprietary therapy apabetalone (RVX-208) ... Read more

March 20, 2019March 20, 2019

Opsumit Has Potential to Improve Right Ventricle Function in PAH Patients, Phase 4 Data Show

News, PAH News

Treatment with Opsumit (macitentan) can significantly improve the heart’s right ventricular function, reverse cardiac tissue remodeling, and reduce pulmonary vascular resistance (PVR) in patients with pulmonary arterial hypertension (PAH), preliminary ... Read more

March 18, 2019March 18, 2019

Cell Therapies Show Potential as Treatment for PAH, Review Finds

News, PAH News

Regenerative cell therapy can induce significant improvements in key clinical features of pulmonary arterial hypertension (PAH) in animal models, a review study shows. The study’s findings suggest that such ... Read more

March 15, 2019March 15, 2019

Defining Five Main Categories of Pulmonary Wellness: A Rehab Specialist’s Advice

News

“The whole is greater than the sum of its parts.” — Aristotle In today’s healthcare environment, an overwhelming percentage of resources are spent on treating diseases and their associated manifestations. ... Read more

March 15, 2019March 15, 2019

Estrogen May Help Protect Against Heart Changes in PAH, Animal Study Suggests

News, PAH News

Estrogen, one of the major female sex hormones, has a protective effect in pulmonary arterial hypertension (PAH) by halting oxidative stress and collagen deposition, a rat study suggests. The ... Read more

March 15, 2019March 19, 2019

PH Life Feels Like Residing in a Waiting Room

Columns, Recharged and Rewired - a Column by Brittany Foster

I get anxious just thinking about what it’s like sitting in a waiting room at a doctor’s office. In waiting rooms, I pretend to keep myself occupied and distracted ... Read more

March 14, 2019March 19, 2019

Liquidia’s LIQ861 Safe and Effective in PAH Patients, Phase 3 Trial Suggests

News, PAH News

A Phase 3 clinical trial testing LIQ861 met its primary objective, showing that the investigational inhaled dry powder treprostinil formulation is safe and effective for the treatment of pulmonary arterial hypertension (PAH), according ... Read more

March 14, 2019March 20, 2019

Brexit Could Have Real Effects for UK Rare Disease Patients, Experts Warn

News

Madeline Collin, a 24-year-old activist with Gaucher disease, worries that patients like her will suffer deeply if Britain leaves the European Union (EU), as scheduled, at the end of ... Read more

March 13, 2019March 13, 2019

1st Participant Enrolled in Phase 2 Trial of Levosimendan for PH Patients with Heart Failure

News, PH News

The first participant has been enrolled in a Phase 2 trial testing the investigational therapy levosimendan in pulmonary hypertension (PH) patients with heart failure and preserved ejection fraction (PH-HFpEF). Ejection ... Read more

March 12, 2019March 12, 2019

Moral Dilemmas Complicate Treatment of Rare Diseases, Says Israeli Bioethicist

News

With each new advance in medicine comes ethical dilemmas, from fertility treatments and newborn screening, to vaccinations, gene therapies and euthanasia. But rare diseases and the expensive therapies needed ... Read more

March 11, 2019March 11, 2019

Study Reveals Possible Reason for Women’s Higher Risk of PAH

News, PAH News

Women’s pulmonary artery muscle cells produce more of a signal molecule called hypoxia-inducible factor 1-alpha (HIF1α), which may contribute to the higher prevalence of pulmonary arterial hypertension (PAH) in women compared ... Read more

March 8, 2019March 15, 2019

With PH, I Choose to Be Cautiously Optimistic

Columns, Recharged and Rewired - a Column by Brittany Foster

Black-and-white thinking is something that I have mastered for the majority of my life. In the psychology world, the term for this type of thinking is called “splitting.” According ... Read more